- Home
- CARS vs BBNX Comparison
CARS vs BBNX Comparison
Compare CARS & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARS
- BBNX
- Stock Information
- Founded
- CARS 1998
- BBNX 2015
- Country
- CARS United States
- BBNX United States
- Employees
- CARS N/A
- BBNX N/A
- Industry
- CARS Motor Vehicles
- BBNX Medical/Dental Instruments
- Sector
- CARS Consumer Discretionary
- BBNX Health Care
- Exchange
- CARS Nasdaq
- BBNX Nasdaq
- Market Cap
- CARS 815.4M
- BBNX 740.7M
- IPO Year
- CARS 2017
- BBNX 2025
- Fundamental
- Price
- CARS $13.59
- BBNX $20.20
- Analyst Decision
- CARS Strong Buy
- BBNX Strong Buy
- Analyst Count
- CARS 5
- BBNX 10
- Target Price
- CARS $17.30
- BBNX $24.40
- AVG Volume (30 Days)
- CARS 800.7K
- BBNX 569.5K
- Earning Date
- CARS 08-07-2025
- BBNX 07-29-2025
- Dividend Yield
- CARS N/A
- BBNX N/A
- EPS Growth
- CARS 69.36
- BBNX N/A
- EPS
- CARS 0.63
- BBNX N/A
- Revenue
- CARS $717,845,000.00
- BBNX $69,830,000.00
- Revenue This Year
- CARS $2.52
- BBNX $42.80
- Revenue Next Year
- CARS $2.93
- BBNX $34.58
- P/E Ratio
- CARS $21.62
- BBNX N/A
- Revenue Growth
- CARS 0.68
- BBNX 38911.17
- 52 Week Low
- CARS $9.56
- BBNX $8.89
- 52 Week High
- CARS $20.47
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- CARS 59.20
- BBNX N/A
- Support Level
- CARS $12.63
- BBNX N/A
- Resistance Level
- CARS $13.47
- BBNX N/A
- Average True Range (ATR)
- CARS 0.47
- BBNX 0.00
- MACD
- CARS 0.06
- BBNX 0.00
- Stochastic Oscillator
- CARS 81.64
- BBNX 0.00
About CARS Cars.com Inc.
Cars.com Inc is an online destination for buying and selling new and used vehicles. It is an audience-driven technology company empowering the automotive industry. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.